Empirical antibiotics targeting Gram-positive bacteria for the treatment of febrile neutropenic patients with cancer.

The pattern of infections among neutropenic cancer patients has shifted in the last decades to a predominance of Gram-positive infections. Some of these Gram-positive bacteria are increasingly resistant to beta-lactams and necessitate specific antibiotic treatment.